VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study

dc.date.accessioned	2024-04-23T15:04:36Z
dc.date.available	2024-04-23T15:04:36Z
dc.date.created	2024-04-15T08:56:44Z
dc.date.issued	2024
dc.identifier.citation	Nørgaard, Jakob Nordberg Moore, Kari Lenita Falck Slørdahl, Tobias Schmidt Vik, Anders Tvedt, Tor Henrik Anderson Schjesvold, Fredrik . VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study. Blood Cancer Journal. 2024, 14(60)
dc.identifier.uri	http://hdl.handle.net/10852/110635
dc.language	EN
dc.rights	Attribution 4.0 International
dc.rights.uri	https://creativecommons.org/licenses/by/4.0/
dc.title	VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study
dc.title.alternative	ENEngelskEnglishVRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study
dc.type	Journal article
dc.creator.author	Nørgaard, Jakob Nordberg
dc.creator.author	Moore, Kari Lenita Falck
dc.creator.author	Slørdahl, Tobias Schmidt
dc.creator.author	Vik, Anders
dc.creator.author	Tvedt, Tor Henrik Anderson
dc.creator.author	Schjesvold, Fredrik
cristin.unitcode	185,53,49,11
cristin.unitname	Avdeling for blodsykdommer
cristin.ispublished	true
cristin.fulltext	original
cristin.qualitycode	1
dc.identifier.cristin	2261508
dc.identifier.bibliographiccitation	info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Blood Cancer Journal&rft.volume=14&rft.spage=&rft.date=2024
dc.identifier.jtitle	Blood Cancer Journal
dc.identifier.volume	14
dc.identifier.issue	1
dc.identifier.doi	https://doi.org/10.1038/s41408-024-01047-1
dc.type.document	Tidsskriftartikkel
dc.type.peerreviewed	Peer reviewed
dc.source.issn	2044-5385
dc.type.version	PublishedVersion
cristin.articleid	60